While it may be challenging to differentiate between OCD and other anxiety disorders, using a multi-informant assessment and understanding the content of a patient’s fears is a fundamental start to outlining an effective treatment plan.
OCD symptoms can be quite difficult to recognize. Not understanding what is happening, patients tend to be ashamed and suffer in silence, often resulting in a period of 8 to 10 years of untreated illness and long-term negative outcomes.
This review highlights an important diagnostic and therapeutic task: the importance of differentiating true bipolar disorder/obsessive-compulsive disorder comorbidity from BD with secondary OCD.
Despite heterogeneity in symptoms, there is growing realization that common neurobiological processes may contribute to OCD vulnerability and its persistence.
The articles in this Special Report focus on the interplay between trauma and its consequences, including violent behaviors, substance use disorders, and stroke. Taken together, the articles may contribute to a better understanding of—and treatment development for—patients exposed to trauma.
Ultimately, the decision about involuntary treatment is about risk, not predictable outcomes. In many cases, however, these decisions are much more difficult and, until our crystal balls arrive, our best efforts may still fall short.
Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.
This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.
With their early age of onset, high prevalence, chronicity, and pervasive impact on multiple domains of functioning, the burden of mood disorders exceeds that of virtually all medical conditions in the US and globally in terms of disability, cost, and suffering.
Just as the progress over recent decades has improved the clinical evaluation and management of BD among children and adolescents, the remaining gaps serve to inform future progress.